CRO Partners

BioClinica currently works with hundreds of clinical trial outsourcing firms worldwide. Our partnerships with industry-leading technology and service companies expand the range of services available to our clients.  Please view a list of our current partners below.


MedSource

MedSource is recognized as a niche clinical research organization (CRO) focusing on providing support for the most complex clinical trials. Either working in a challenging therapeutic area or with a sophisticated trial design, our experienced team excels at delivering quality results for each and every project. With experience gained from over 400 clinical trials, MedSource has developed specific expertise in conducting oncology and early phase clinical trials in North America. MedSource began as a specialized clinical monitoring group and has consistently expanded to add services and staff to increase the value that we can deliver for our clients. Our services include clinical monitoring, clinical project management, regulatory affairs and submissions, QA auditing, study start-up services, feasibility and site selection, safety monitoring, and medical monitoring. We continue to focus on our core areas of expertise and partner with vendors we consider "best-in-class" to deliver a consolidated service offering to meet each clients individualized needs.

www.medsource.com

 

MMS Holdings, Inc.

MMS Holdings, Inc. and BioClinica have formed a strategic alliance to offer pharmaceutical companies an edge with a more streamlined approach in Phase 1-4 EDC services.

MMS is a niche CRO specializing in clinical programming, biostatistics, medical and regulatory writing, and comprehensive pharmacovigilance services. MMS is headquartered in Michigan with Asia operations in Bangalore, India. MMS is a highly experienced pharmaceutical service organization that is focused on quality deliverables. Senior leadership and much of the staff have over a decade of hands-on pharma experience including multiple submission experience. This commitment to quality deliverables, combined with robust submission experience, sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO-9001:2008 certified for all services and maintains detailed quality metrics for every project. MMS works with BioClinica in understanding your clinical trail needs to optimize results, cost, and productivity on all levels. With impeccable attention to detail and experience you can trust, MMS is the best choice to support your project’s data output and reporting needs.

www.mmsholdings.com

 

PRL Central Laboratory Services

PRL Central Laboratory Services one of the best kept secrets in the business, a great value with incredible service. We specialize in comprehensive diagnostic testing, with a focus on protocol requirements.  We serve all phases of clinical research on a global basis, providing each client with accurate study set-up, timely results delivery and validated data management.  Our credentialed and tenured laboratory professionals employ advanced clinical testing systems in a state-of-the-art facility.  Comprehensive quality control and proficiency testing programs verify accuracy and reliability.  PRL is operational 24 hours per day, 7 days per week, which provides the necessary flexibility to meet project needs and insure rapid results turnaround.  

We excel in:

  • Solutions Oriented Project Management
  • Scientific Consultation Services 
  • Personalized Logistics Management
  • Timely Laboratory Data Management/and Reporting
  • Flexible Reporting Options


http://www.prlnet.com/home.htm

 

Health Sciences International, Inc.

Health Sciences International, Inc. (HSI) is a comprehensive clinical research organization (CRO) which was established in 1997. HSI has a unique business model which assures that Phase I-IV clinical trials meet milestone timelines while adhering to enforceable SOPs, GCP, Standards of the Industry and CFR/ ICH Guidelines.   HSI specializes in cardiology, vascular disorders, endocrinology, internal medicine and CNS therapeutic areas. With worldwide capabilities that include: Protocol and CRF Design, Medical Affairs, Medical Monitoring, Clinical Operations, Project Management, Drug Research & Development, Safety and Pharmacovigilance,  Ambulatory BP & EKG Monitoring, Medical Writing, Medical Science Liaisons, Data Management  and Biostatistics, Site Selection and Feasibility, REMS/ registry/Health Outcome Systems creating customized and intelligent solutions that assure deliverables to meet the goals of our clients while reducing time to market and overhead expenses.  HSI has a commitment to patient safety through professional Educational Marketing and supportive direct to consumer capabilities, conferences, seminars and CME/ CEU accreditation. HSI has a stellar reputation in the industry that excels in Leadership, Integrity, Vision and Excellence (LIVE) and prides itself with “first-rate” collaborative partners such as BioClinica.

http://www.hsiresearch.org/